Microvascular Therapeutics Inc.

Tucson, AZ

UEI
ZA54X6LR5AS3
CAGE
7LE82
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1635 E 18th St, Tucson, AZ 85719, USA
Website
mvtpharma.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
IND enabling studies for targeted phase shift microbubbles for sonothrombolysis HT94252310893 Defense Health Agency $3,984,239
Selectivity and efficacy of CD90-targeted phase shift microbubbles for hifu-mediated non-thermal ablation of brain… R43CA272149 National Cancer Institute (NIH) $795,194
Ultrasound-mediated thrombolysis for MVO and PAO treatment. R33HL156350 National Heart Lung and Blood Institute (NIH) $3,000,486
Targeted ultrasound contrast agents for the disruption of alzheimer's plaques. R43AG067894 National Institute on Aging (NIH) $364,170
Ultrasound-stimulated phase-change contrast agents for sonothrombolysis. R43HL152819 National Heart Lung and Blood Institute (NIH) $378,190

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
FUS Instruments Inc. UEI NCQNBMEF8WD3 Toronto, ON 621511 Medical Laboratories
Sonic Concepts, Inc. UEI TD8BFKW473F8 Bothell, WA 339999 All Other Miscellaneous Manufacturing
Cordance Medical Inc. UEI X7NLMYNHPF66 Mountain View, CA 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
Iconeus UEI NJWHGMTK81A5 Antony, IDF 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Verasonics, Inc. UEI NGBNFHANN243 Kirkland, WA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Microvascular Therapeutics Inc. is a for-profit biotechnology company focused on developing targeted ultrasound contrast agents and delivery systems for diagnostic and therapeutic applications. As per SAM.gov records, the company has been a registered federal government vendor since 2016. Through various prime and subaward grants from agencies including the NIH, DoD, and NSF, Microvascular Therapeutics provides research and development services aimed at advancing ultrasound and microbubble technologies for biomedical applications.

Specifically, Microvascular Therapeutics has been awarded federal grants to conduct preclinical research on microbubbles and nanodroplets for enhanced ultrasound imaging and treatment of cardiovascular diseases, cancer, and neurological disorders. Project activities include formulation of ligand-targeted and acoustically-active nanoparticles, evaluation of binding selectivity and drug delivery capabilities, and testing of thrombus disruption and non-thermal tumor ablation efficacy in animal models. Major grant programs supporting this work include the NIH SBIR and STTR programs, the DoD Military Medical Research and Development program, and the NSF Engineering Research Centers program. Partners on funded projects have included university research groups and medical device manufacturers seeking to translate the technologies for clinical use. Through this body of federally-funded research, Microvascular Therapeutics provides specialized contrast agent platforms, analytical testing services, and translational expertise to advance ultrasonic theranostics.

Quick answers

Is Microvascular Therapeutics Inc. registered in SAM.gov?

Yes. Microvascular Therapeutics Inc.'s SAM.gov registration is active through January 29, 2027.

What is Microvascular Therapeutics Inc.'s CAGE code?

Microvascular Therapeutics Inc.'s CAGE code is 7LE82, and its Unique Entity ID (UEI) is ZA54X6LR5AS3.

What is Microvascular Therapeutics Inc.'s most recent federal award?

Microvascular Therapeutics Inc.'s most recent federal grant award is IND enabling studies for targeted phase shift microbubbles for sonothrombolysis (HT94252310893), from Defense Health Agency, on September 1, 2023.

On GovTribe

See Microvascular Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe